CJC-1295 is a 30-residue GHRH analog available in two forms — with DAC (long-acting albumin binding) and no-DAC (short pulsatile). Full profile inside.
CJC-1295 is a 30-residue analog of GHRH(1-29) engineered with substitutions that confer enzymatic stability. The molecule exists in two research forms — with and without the DAC linker — that behave very differently pharmacokinetically.
Two forms
- With DAC — maleimide-based Drug Affinity Complex, binds albumin covalently, extends half-life to multi-day range.
- No-DAC (also called Mod GRF 1-29) — short half-life, preserves natural pulsatile GH kinetics.
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.
